331 related articles for article (PubMed ID: 38192931)
1. Liquid Biopsy: An Evolving Paradigm for Non-invasive Disease Diagnosis and Monitoring in Medicine.
Adhit KK; Wanjari A; Menon S; K S
Cureus; 2023 Dec; 15(12):e50176. PubMed ID: 38192931
[TBL] [Abstract][Full Text] [Related]
2. Liquid biopsy: current technology and clinical applications.
Nikanjam M; Kato S; Kurzrock R
J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
[TBL] [Abstract][Full Text] [Related]
3. Liquid biopsy for precision diagnostics and therapeutics.
Anitha K; Posinasetty B; Naveen Kumari K; Chenchula S; Padmavathi R; Prakash S; Radhika C
Clin Chim Acta; 2024 Feb; 554():117746. PubMed ID: 38151071
[TBL] [Abstract][Full Text] [Related]
4. Liquid biopsy based biomarkers in non-small cell lung cancer for diagnosis and treatment monitoring.
Pérez-Callejo D; Romero A; Provencio M; Torrente M
Transl Lung Cancer Res; 2016 Oct; 5(5):455-465. PubMed ID: 27826527
[TBL] [Abstract][Full Text] [Related]
5. Cell Free DNA as an Evolving Liquid Biopsy Biomarker for Initial Diagnosis and Therapeutic Nursing in Cancer- An Evolving Aspect in Medical Biotechnology.
Ray SK; Mukherjee S
Curr Pharm Biotechnol; 2022; 23(1):112-122. PubMed ID: 33308128
[TBL] [Abstract][Full Text] [Related]
6. Advanced liquid biopsy technologies for circulating biomarker detection.
Soda N; Rehm BHA; Sonar P; Nguyen NT; Shiddiky MJA
J Mater Chem B; 2019 Nov; 7(43):6670-6704. PubMed ID: 31646316
[TBL] [Abstract][Full Text] [Related]
7. Liquid biopsy in breast cancer: A comprehensive review.
Alimirzaie S; Bagherzadeh M; Akbari MR
Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
[TBL] [Abstract][Full Text] [Related]
8. Unlocking the future of cancer diagnosis - promises and challenges of ctDNA-based liquid biopsies in non-small cell lung cancer.
Reina C; Šabanović B; Lazzari C; Gregorc V; Heeschen C
Transl Res; 2024 Jun; 272():41-53. PubMed ID: 38838851
[TBL] [Abstract][Full Text] [Related]
9. Application of liquid biopsy in precision medicine: opportunities and challenges.
Wang J; Chang S; Li G; Sun Y
Front Med; 2017 Dec; 11(4):522-527. PubMed ID: 28744793
[TBL] [Abstract][Full Text] [Related]
10. Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer.
Casanova-Salas I; Athie A; Boutros PC; Del Re M; Miyamoto DT; Pienta KJ; Posadas EM; Sowalsky AG; Stenzl A; Wyatt AW; Mateo J
Eur Urol; 2021 Jun; 79(6):762-771. PubMed ID: 33422353
[TBL] [Abstract][Full Text] [Related]
11. Liquid biopsy in T-cell lymphoma: biomarker detection techniques and clinical application.
Huang Z; Fu Y; Yang H; Zhou Y; Shi M; Li Q; Liu W; Liang J; Zhu L; Qin S; Hong H; Liu Y
Mol Cancer; 2024 Feb; 23(1):36. PubMed ID: 38365716
[TBL] [Abstract][Full Text] [Related]
12. Current and Future Perspectives of Cell-Free DNA in Liquid Biopsy.
Liu S; Wang J
Curr Issues Mol Biol; 2022 Jun; 44(6):2695-2709. PubMed ID: 35735625
[TBL] [Abstract][Full Text] [Related]
13. Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes.
Giannopoulou L; Zavridou M; Kasimir-Bauer S; Lianidou ES
Transl Res; 2019 Mar; 205():77-91. PubMed ID: 30391474
[TBL] [Abstract][Full Text] [Related]
14. Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management.
Elazezy M; Joosse SA
Comput Struct Biotechnol J; 2018; 16():370-378. PubMed ID: 30364656
[TBL] [Abstract][Full Text] [Related]
15. Liquid Biopsy in Lung Cancer: Clinical Applications of Circulating Biomarkers (CTCs and ctDNA).
Lim M; Kim CJ; Sunkara V; Kim MH; Cho YK
Micromachines (Basel); 2018 Feb; 9(3):. PubMed ID: 30424034
[TBL] [Abstract][Full Text] [Related]
16. Advances in liquid biopsy using circulating tumor cells and circulating cell-free tumor DNA for detection and monitoring of breast cancer.
Zhang X; Ju S; Wang X; Cong H
Clin Exp Med; 2019 Aug; 19(3):271-279. PubMed ID: 31190187
[TBL] [Abstract][Full Text] [Related]
17. The potential of liquid biopsies in gastrointestinal cancer.
Wu C; Zhang J; Li H; Xu W; Zhang X
Clin Biochem; 2020 Oct; 84():1-12. PubMed ID: 32540214
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma.
Huang X; Duijf PHG; Sriram S; Perera G; Vasani S; Kenny L; Leo P; Punyadeera C
J Biomed Sci; 2023 Aug; 30(1):65. PubMed ID: 37559138
[TBL] [Abstract][Full Text] [Related]
19. Advances in novel strategies for isolation, characterization, and analysis of CTCs and ctDNA.
Yaghoubi Naei V; Bordhan P; Mirakhorli F; Khorrami M; Shrestha J; Nazari H; Kulasinghe A; Ebrahimi Warkiani M
Ther Adv Med Oncol; 2023; 15():17588359231192401. PubMed ID: 37692363
[TBL] [Abstract][Full Text] [Related]
20. Liquid biopsy, a paradigm shift in oncology: what interventional radiologists should know.
Calandri M; Siravegna G; Yevich SM; Stranieri G; Gazzera C; Kopetz S; Fonio P; Gupta S; Bardelli A; Veltri A; Odisio BC
Eur Radiol; 2020 Aug; 30(8):4496-4503. PubMed ID: 32193642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]